About
Oryzon Genomics Sa (MC:ORY) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 27 2026
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
Feb 19 2026
ORYZON to Participate in Upcoming Events in February and March
Feb 12 2026
ORYZON Announces Appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS
Feb 9 2026
ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in Extensive Stage Small Cell Lung Cancer
Feb 2 2026
ORYZON Strengthens Patent Portfolio for Vafidemstat With New Decision to Grant in Japan
Financials
Revenue
€10.93 M
Market Cap
€220 M
EPS
-0.03
Translate